Vasospastic angina in women: Clinical backgrounds and prognoses of patients younger than and older than 60 years

Table 4 Vasospastic angina-related parameters in the two groups

			Group O	Group Y	P value
Chest symptoms
Rest/Exercise/Both			60/9/9	14/1/2	0.78
Maximum duration of attack (min)			20 ± 27	16 ± 28	0.10
Diseased duration (M)			5 (1, 48)	12 (3, 42)	0.78
No. of anginal attacks (/M)
	At admission		4 (1, 10)	4 (1, 10)	0.43
	At follow-up		0 (0, 1)	2 (0.1, 2.8)	< 0.01
		No.	69	16
Medications
Taking statins at admission (%)			36 (47)	7 (46)	0.68
Taking antiplatelet drugs at admission (%)			20 (26)	1 (6)	0.07
Taking vasodilators at admission (%)			38 (49)	3 (18)	0.02
No. coronary vasodilators
	At admission		0 (0,1)	0 (0, 0)	0.01
			0.6 ± 0.7	0.2 ± 0.4	0.01
	At discharge		1 (1, 1)	1 (1, 1)	0.01
			1.2 ± 0.5	0.9 ± 0.3	0.02
	At follow-up		1 (1, 2)	1.5 (1, 2)	0.52
			1.5 ± 0.9	1.6 ± 0.9	0.53

M: Months; No.: Number; VSA: Vasospastic angina; Group O: Older than 60 years of age; Group Y: Younger than 60 years of age.